Please be aware that this website relies on the use of cookies to function correctly and involves some cookies being downloaded onto your device. By continuing to use this website, you agree to our use of these cookies. This helps us to improve the content of the website so that it is more useful and relevant to you. For more information please see our Privacy Policy.

PACE

Patient Access to Cancer care Excellence


A Global Vision

Faster steps forward: towards cures for cancer and access to best treatment and care for individual patients.

Learn more about PACE

Clifford Goodman, Ph.D.

Dr. Goodman is a Senior Vice President at The Lewin Group, a health care policy and human services consulting firm located near Washington, D.C. He has 30 years of experience in health care evaluation, including HTA, evidence-based health care, comparative effectiveness research (CER), health economics, and studies pertaining to health care innovation, regulation and payment. He directs studies and projects for an international range of government agencies; pharmaceutical, biotechnology and medical device companies; health care provider institutions; and professional, industry and patient advocacy groups. His recent work has involved such areas as oncology, cardiovascular disease, diabetes, obesity, end-stage renal disease, pandemic influenza, biosimilars, wound care, pharmacogenomics, diagnostic testing, organ donation and transplantation, and personalized medicine.

Dr. Goodman is senior staff on the Lewin Group Center for CER, on such efforts as a national inventory for CER, a national horizon scanning system, and a multi-payer claims database. He directed a Lewin team that provided technical support for the U.S. Federal Coordinating Council for Comparative Effectiveness Research (including its Report to the President and The Congress, 2009). For the U.S. Agency for Healthcare Research and Quality (AHRQ), he directed the Evidence-based Practice Centers Coordinating Center at The Lewin Group (2002-08). Dr. Goodman is chair of the Medicare Evidence Development & Coverage Advisory Committee (MEDCAC) for the U.S. Centers for Medicare and Medicaid Services (CMS). He has testified to Congress on issues pertaining to Medicare coverage of health care technology. Dr. Goodman is a frequent health policy issues moderator and facilitator of expert panels, workshops and health industry advisory boards. Earlier in his career, as a National Research Council Fellow and later as director of the Council on Health Care Technology, he managed and staffed a series of HTA projects at the Institute of Medicine, including the landmark study, Assessing Medical Technologies. Subsequently, he was a visiting researcher in Stockholm at the Swedish Council on Technology Assessment in Health Care (SBU). He is a founding board member of HTAi. He is a Fellow of the American Institute for Medical and Biological Engineering. He serves on the editorial boards of the International Journal of Technology Assessment in Health Care and the American Journal of Managed Care. He did his undergraduate work at Cornell University, received a master's degree from the Georgia Institute of Technology, and earned his doctorate from the Wharton School of the University of Pennsylvania.